Table 1 Evaluation of selected serum chemistries 5 days after intratumoral injection of AdCA-mIFN
AdCA-mIFN | AdCA-AP | No treatment | |||
---|---|---|---|---|---|
Dose (PFU): × 10 8 | 2.5 | 1.0 | 0.25 | 2.5 | — |
Mouse IFN concentration | |||||
Tumour (pg g−1): × 103 | 252.3±292.2 | 53.0±30.0 | 14.3±13.4 | 1.4±0.6 | 0.8±0.2 |
Serum (pg ml−1): × 103 | 1.7±0.9 | 0.3±0.1 | 0.3±0.2 | 0.2±0.1 | 0.2±0.1 |
Albumin (g dl−1) | 2.8±0.3 | 2.9±0.4 | 2.8±0.4 | 2.7±0.1 | 2.9±0.3 |
Alk. phos. (IU l−1) | 231±71 | 186±29 | 199±44 | 186±21 | 218±81 |
Amylase (U l−1) | 13 910±3932 | 16 595±6937 | 17 790±453 | 14 850±353 | 10 269±3922 |
BUN (mg dl−1) | 19.1±1.6 | 23.6±6.4 | 21.2±2.4 | 22.7±1.3 | 23.9±4.0 |
Creatinine (mg dl−1) | 0.08± 0.02 | 0.09± 0.02 | 0.1±0.01 | 0.09±0.02 | 0.11±0.03 |
LDH (IU l−1) | 379± 69 | 316±68 | 560±244 | 486±252 | 368±216 |
AST (IU l−1) | 126±4 | 101±42 | 93±34 | 68±17 | 70±23 |
ALT (IU l−1) | 54±32 | 28±4 | 25±7 | 18±10 | 19±5 |
T. bil. (mg dl−1) | 0.05±0.01 | 0.04±0.01 | 0.05±0.01 | 0.06±0.01 | 0.04±0.01 |